|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues: | |||||
| Net product revenue | |||||
| Product | |||||
| License | |||||
| Total net product revenue | |||||
| Licensing revenue | |||||
| Royalties and other revenue | |||||
| Total revenues | |||||
| Operating expenses: | |||||
| Cost of sales | |||||
| Research and development | |||||
| Selling, General and Administrative Expense | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest and other expense | |||||
| Interest income and other | |||||
| Net loss | |||||
| Net loss per common share, basic (usd per share) | |||||
| Net loss per common share, diluted (usd per share) | |||||
| Shares used in computing net loss per common share, basic | |||||
| Shares used in computing net loss per common share, diluted | |||||
| Other comprehensive loss: | |||||
| Unrealized (loss) gain on investments | |||||
| Comprehensive loss | |||||
Loading...